1,2,3,4-tetrahydroisoquinoline and Colonic Neoplasms

1,2,3,4-tetrahydroisoquinoline has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, B; He, G; Huang, H; Huang, W; Liu, SJ; Peng, C; Zhao, Q; Zhong, YJ	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Colonic Neoplasms

Article	Year
Asymmetric synthesis of tetrahydroisoquinoline-fused spirooxindoles as Ras-GTP inhibitors that inhibit colon adenocarcinoma cell proliferation and invasion. Chemical communications (Cambridge, England), 2018, Jul-24, Volume: 54, Issue:60 Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; Humans; Indoles; Molecular Conformation; ras Proteins; Spiro Compounds; Structure-Activity Relationship; Tetrahydroisoquinolines	2018

Article

Year

Asymmetric synthesis of tetrahydroisoquinoline-fused spirooxindoles as Ras-GTP inhibitors that inhibit colon adenocarcinoma cell proliferation and invasion.

Chemical communications (Cambridge, England), 2018, Jul-24, Volume: 54, Issue:60

Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; Humans; Indoles; Molecular Conformation; ras Proteins; Spiro Compounds; Structure-Activity Relationship; Tetrahydroisoquinolines

2018